- Home
- WYY vs NVNO Comparison
WYY vs NVNO Comparison
Compare WYY & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- NVNO
- Stock Information
- Founded
- WYY 1991
- NVNO 1987
- Country
- WYY United States
- NVNO United States
- Employees
- WYY N/A
- NVNO N/A
- Industry
- WYY EDP Services
- NVNO Medical/Dental Instruments
- Sector
- WYY Technology
- NVNO Health Care
- Exchange
- WYY Nasdaq
- NVNO Nasdaq
- Market Cap
- WYY 35.6M
- NVNO 41.0M
- IPO Year
- WYY 1998
- NVNO N/A
- Fundamental
- Price
- WYY $5.47
- NVNO $3.65
- Analyst Decision
- WYY Strong Buy
- NVNO
- Analyst Count
- WYY 1
- NVNO 0
- Target Price
- WYY $7.00
- NVNO N/A
- AVG Volume (30 Days)
- WYY 83.5K
- NVNO 76.7K
- Earning Date
- WYY 05-15-2025
- NVNO 05-01-2025
- Dividend Yield
- WYY N/A
- NVNO N/A
- EPS Growth
- WYY N/A
- NVNO N/A
- EPS
- WYY N/A
- NVNO N/A
- Revenue
- WYY $142,571,749.00
- NVNO N/A
- Revenue This Year
- WYY $10.84
- NVNO N/A
- Revenue Next Year
- WYY $12.37
- NVNO $409.09
- P/E Ratio
- WYY N/A
- NVNO N/A
- Revenue Growth
- WYY 34.47
- NVNO N/A
- 52 Week Low
- WYY $2.19
- NVNO $2.03
- 52 Week High
- WYY $6.25
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- WYY 83.82
- NVNO 71.64
- Support Level
- WYY $4.78
- NVNO $2.61
- Resistance Level
- WYY $5.24
- NVNO $3.97
- Average True Range (ATR)
- WYY 0.47
- NVNO 0.22
- MACD
- WYY 0.21
- NVNO 0.11
- Stochastic Oscillator
- WYY 98.88
- NVNO 80.00
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.